Medy-Tox Market Cap

Medy-Tox has a market cap or net worth of 650.27 billion as of May 19, 2026. Its market cap has decreased by -39.62% in one year.

Market Cap

650.27B

Enterprise Value

680.62B

Revenue

247.29B

Ranking

n/a

PE Ratio

41.84

Stock Price

97,400.00

Market Cap Chart

Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 650.27B, an increase of 806.62%. That is a compound annual growth rate of 13.55%.

Market Cap History

Date	Market Cap	% Change
May 19, 2026	650.27B	-23.32%
Dec 30, 2025	847.99B	2.03%
Dec 30, 2024	831.10B	-48.75%
Dec 28, 2023	1.62T	101.16%
Dec 29, 2022	806.18B	-7.99%
Dec 30, 2021	876.20B	-13.91%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Pharmicell	1.03T
Onconic Therapeutics	876.66B
GI Innovation	819.03B
MEDIPOST	707.84B
GC Corp.	681.03B
Proteina	533.30B
SillaJen	428.82B
Genomictree	350.34B

Market Cap Rankings